Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/65350
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record
DISEASE X IN THE TROPICS, PREVENTING THE NEXT PANDEMIC: HOW TO ACCELERATE SPILLOVER PREVENTION AND VACCINE PREPAREDNESS?
Pandemic
Preparedness
COVID-19
Spillover prevention
Vaccines
Artificial intelligence
Author
Affilliation
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
University of Pittsburgh. Department of Infectious Diseases and Microbiolog. PA, United States / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
University of Pittsburgh. Department of Infectious Diseases and Microbiolog. PA, USA.
University of Kansas. Department of Pharmaceutical Chemistry. Vaccine Analytics and Formulation Center. Lawrence, KS, USA,
International Vaccine Institute. Director General Office. Seoul, Republic of Korea / Seoul National University. College of Natural Sciences. Seoul, Republic of Korea.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
University of Pittsburgh. Department of Infectious Diseases and Microbiolog. PA, United States / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Recife, PE, Brasil.
University of Pittsburgh. Department of Infectious Diseases and Microbiolog. PA, USA.
University of Kansas. Department of Pharmaceutical Chemistry. Vaccine Analytics and Formulation Center. Lawrence, KS, USA,
International Vaccine Institute. Director General Office. Seoul, Republic of Korea / Seoul National University. College of Natural Sciences. Seoul, Republic of Korea.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
Keywords
Disease XPandemic
Preparedness
COVID-19
Spillover prevention
Vaccines
Artificial intelligence
Share